GR3029399T3 - Method of preparing a radioactive rhenium complex solution. - Google Patents

Method of preparing a radioactive rhenium complex solution.

Info

Publication number
GR3029399T3
GR3029399T3 GR990400483T GR990400483T GR3029399T3 GR 3029399 T3 GR3029399 T3 GR 3029399T3 GR 990400483 T GR990400483 T GR 990400483T GR 990400483 T GR990400483 T GR 990400483T GR 3029399 T3 GR3029399 T3 GR 3029399T3
Authority
GR
Greece
Prior art keywords
sertindole
group
iii
optionally substituted
nr2r3
Prior art date
Application number
GR990400483T
Other languages
English (en)
Inventor
Jens Kristian Perregaard
Henrik Perdersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of GR3029399T3 publication Critical patent/GR3029399T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
GR990400483T 1990-10-03 1999-02-12 Method of preparing a radioactive rhenium complex solution. GR3029399T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK238190A DK238190D0 (da) 1990-10-03 1990-10-03 Depotderivater
PCT/DK1991/000291 WO1992006089A1 (en) 1990-10-03 1991-09-27 Sertindole prodrugs

Publications (1)

Publication Number Publication Date
GR3029399T3 true GR3029399T3 (en) 1999-05-28

Family

ID=8111993

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990400483T GR3029399T3 (en) 1990-10-03 1999-02-12 Method of preparing a radioactive rhenium complex solution.

Country Status (21)

Country Link
US (1) US5428036A (el)
EP (1) EP0592433B1 (el)
JP (1) JP3100980B2 (el)
KR (1) KR100212430B1 (el)
AT (1) ATE175964T1 (el)
AU (1) AU652783B2 (el)
CA (1) CA2093433C (el)
DE (1) DE69130803T2 (el)
DK (2) DK238190D0 (el)
ES (1) ES2125870T3 (el)
FI (1) FI102679B (el)
GR (1) GR3029399T3 (el)
HK (1) HK1009273A1 (el)
IE (1) IE913384A1 (el)
IL (1) IL99652A (el)
NO (1) NO301475B1 (el)
NZ (1) NZ240051A (el)
PH (1) PH30129A (el)
PT (1) PT99142B (el)
WO (1) WO1992006089A1 (el)
ZA (1) ZA917881B (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776963A (en) 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5643784A (en) * 1990-12-04 1997-07-01 H, Lundbeck A/S Indan derivatives
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
DK206591D0 (da) * 1991-12-23 1991-12-23 Lundbeck & Co As H Behandling af psykoser
JPH0625964U (ja) * 1992-05-25 1994-04-08 ミクロン機器株式会社 通信機能付きコインカウンタ及び有料装置
US6489341B1 (en) * 1999-06-02 2002-12-03 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
ES2387562T3 (es) 2001-03-23 2012-09-26 Luitpold Pharmaceuticals, Inc. Conjugados alcohol graso-medicamento
EP1427407A4 (en) * 2001-03-23 2005-05-11 Luitpold Pharm Inc CONJUGATES BASED ON FATTY AMINES AND PHARMACEUTICAL AGENTS
US20100168197A1 (en) * 2007-02-28 2010-07-01 Naresh Kumar Muscarinic receptor antagonists
US8431576B2 (en) 2009-06-25 2013-04-30 Alkermes Pharma Ireland Limited Heterocyclic compounds for the treatment of neurological and psychological disorders
JP5732453B2 (ja) * 2009-06-25 2015-06-10 アルカーメス ファーマ アイルランド リミテッド Ｎｈ酸性化合物のプロドラッグ
US8592427B2 (en) * 2010-06-24 2013-11-26 Alkermes Pharma Ireland Limited Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
US11273158B2 (en) 2018-03-05 2022-03-15 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3408356A (en) * 1965-08-31 1968-10-29 Squibb & Sons Inc Long chain esters of 4'-fluoro-4-[4-hydroxy-4-(alpha, alpha, alpha-trifluorotolyl)piperi-dino]butyrophenone and the like
US4038305A (en) * 1972-03-20 1977-07-26 Aktieselskabet Grindstedvaerket Cyclopentenone derivatives
GB1469108A (en) * 1973-06-25 1977-03-30 Kefalas As Thiaxanthene derivative
JPS568318A (en) * 1979-06-28 1981-01-28 Janssen Pharmaceutica Nv Non oral long acting composition of haloperidol and bromperidol derivative
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8621892D0 (en) * 1986-09-11 1986-10-15 Lundbeck & Co As H Organic compound
GB8908085D0 (en) * 1989-04-11 1989-05-24 Lundbeck & Co As H New therapeutic use
DE3921886A1 (de) * 1989-07-04 1991-01-17 Wolfgang Mohr Vorrichtung zum schneiden von gestapeltem, blattfoermigen gut

Also Published As

Publication number Publication date
KR930702335A (ko) 1993-09-08
KR100212430B1 (ko) 1999-08-02
ZA917881B (en) 1992-07-29
NZ240051A (en) 1993-05-26
PH30129A (en) 1997-01-21
AU8710491A (en) 1992-04-28
EP0592433B1 (en) 1999-01-20
DE69130803D1 (de) 1999-03-04
JP3100980B2 (ja) 2000-10-23
FI102679B1 (fi) 1999-01-29
ES2125870T3 (es) 1999-03-16
EP0592433A1 (en) 1994-04-20
PT99142A (pt) 1994-02-28
CA2093433C (en) 2000-11-21
JPH06501939A (ja) 1994-03-03
IE913384A1 (en) 1992-04-08
CA2093433A1 (en) 1992-04-04
IL99652A0 (en) 1992-08-18
HK1009273A1 (en) 1999-05-28
DK0592433T3 (da) 1999-09-13
FI931472A (fi) 1993-04-01
NO931219D0 (no) 1993-03-31
NO931219L (no) 1993-04-01
IL99652A (en) 1997-04-15
AU652783B2 (en) 1994-09-08
FI102679B (fi) 1999-01-29
NO301475B1 (no) 1997-11-03
DK238190D0 (da) 1990-10-03
US5428036A (en) 1995-06-27
DE69130803T2 (de) 1999-08-19
FI931472A0 (fi) 1993-04-01
PT99142B (pt) 1999-04-30
WO1992006089A1 (en) 1992-04-16
ATE175964T1 (de) 1999-02-15

Similar Documents

Publication Publication Date Title
GR3029399T3 (en) Method of preparing a radioactive rhenium complex solution.
ES8400422A1 (es) "procedimiento de preparacion de eteres triciclicos, asi como de sus sales de adicion con un acido mineral u organico terapeuticamente compatible".
IL104305A0 (en) Piperazine derivatives,their preparation and pharmaceutical compositions containing them
ES8301962A1 (es) Un procedimiento para la produccion de un derivado de carboslivilo.
ATE25251T1 (de) Anti srs-a carbonsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische formulierungen.
ATE14579T1 (de) Pharmazeutische heterocyclische verbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen.
FR2698873B1 (fr) Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.
GB973361A (en) Pyrazolo-pyrimidines and process for their manufacture
ATE59033T1 (de) N-enthaltende heterozyklische verbindungen, verfahren zu deren herstellung und diese enthaltende arzneimittel.
KR850003719A (ko) 시아노피라졸 제초제에 대한 개량
AT397654B (de) Neue pleuromutilinderivate, ihre verwendung und verfahren zu ihrer herstellung
ATE13880T1 (de) N-2-hydroxypropyl-piperidine und verfahren zu ihrer herstellung.
TW238304B (en) A process for the preparation of 1-substituted-5(4H)-tetrazolinones
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
ES8500910A1 (es) Un procedimiento para la preparacion de 6-(fenil sustituido)-3(2h)-piridazinonas.
ATE70531T1 (de) Carbacyclinester, verfahren zu ihrer herstellung und ihre verwendung in der medizin.
ATE19879T1 (de) Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GB943276A (en) Derivatives of dibenz[b,f]azepines and process for their production
ATE36520T1 (de) Polyprenylverbindung, ihre herstellung und pharmazeutische verwendung.
FR2485000B1 (el)
HUT53638A (en) Process for producing 15-amino-substituted 20,21-dinoreburnamenie derivatives and pharmaceutical compositions containing them
ES478072A1 (es) Un procedimiento de preparacion de 2-metoxi-benzamidas.
DE69327092D1 (de) Optisch aktives 1-phenylpyrrolidonderivat und dessen herstellung
ES8304540A1 (es) Un procedimiento para producir una nueva carboxiamidoamina-sustituida.